FDA recommends sponsors plan to include race, ethnicity in clinical trial design
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical TrialsCombination products/companion diagnosticsComplianceDiagnostics/IVDsEthicsMedical DevicesNorth AmericaPharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and Development